The Effect of Rectal Progesterone on the Latency period as well as Maternal and Prenatal Outcome in PPROM Between 24-33+6 Weeks

drug protocol number

ISRCTN65694106

drug sponsor

Umm Al Qura University

drug study

Progesterone

drug trial site

UQU

drug status

Ongoing

drug phase